Welcome to the BioLogicTube jeo@biologicmedia.dk https://biologictube.dk/app/facebook en-us Visualplatform http://blogs.law.harvard.edu/tech/rss Welcome to the BioLogicTube episodic no https://biologictube.dk/app/facebook/files/rv0.0/sitelogo.gif https://biologictube.dk/app/facebook http://biologictube.dk/photo/53580443/prof-peter-rossing-on-diabetes <p>Patients with type 1 diabetes are prone to develop complications such as kidney or heart disease. Professor Peter Rossing and his group are working on biomarkers that may predict which patients are in risk of developing these complications. Peter talks about their latest work on the risk biomarker suPAR and its predictive abilities. Their study "Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes" were published in Diabetes Care in 2019 (https://care.diabetesjournals.org/content/42/6/1112.long)</p><p><a href="http://biologictube.dk/photo/53580443/prof-peter-rossing-on-diabetes"><img src="http://biologictube.dk/49543318/53580443/a34f811ef3ad7f14e2072b914382ec3a/standard/download-2-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/53580443 Wed, 03 Jul 2019 12:53:40 GMT Prof. Peter Rossing on diabetes complications Patients with type 1 diabetes are prone to develop complications such as kidney or heart disease. Professor Peter Rossing and his group are working on biomarkers that may predict which patients are in risk of developing these complications. Peter talks about their latest work on the risk biomarker suPAR and its predictive abilities. Their study "Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes" were published in Diabetes Care in 2019 (https://care.diabetesjournals.org/content/42/6/1112.long) Patients with type 1 diabetes are prone to develop complications such as kidney or heart disease. Professor Peter Rossing and his group are working on biomarkers that may predict which patients are in risk of developing these complications. Peter... Welcome to the BioLogicTube 05:34 <p>Patients with type 1 diabetes are prone to develop complications such as kidney or heart disease. Professor Peter Rossing and his group are working on biomarkers that may predict which patients are in risk of developing these complications. Peter talks about their latest work on the risk biomarker suPAR and its predictive abilities. Their study "Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes" were published in Diabetes Care in 2019 (https://care.diabetesjournals.org/content/42/6/1112.long)</p><p><a href="http://biologictube.dk/photo/53580443/prof-peter-rossing-on-diabetes"><img src="http://biologictube.dk/49543318/53580443/a34f811ef3ad7f14e2072b914382ec3a/standard/download-2-thumbnail.jpg" width="600" height="338"/></a></p> cardiovascular complications early intervention early prediction End-stage renal disease ESRD Jesper Eugen-Olsen Jørgen Jeppesen late stage complications Persson F risk prediction Simone Theilade soluble urokinase plasminogen activator receptor suPAR Tine W. Hansen Tofte N Type 1 diabetes Viktor Curovic Winther SA